This is the authors' abstract. We don't add key points for this paper.
A convergent and robust synthesis of a developmental CCR1 antagonist is described using continuous flow technology.
No takes yet. Share an insight, caveat, or question.
Marsini et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: